1. Differential effects of once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide and metformin on pancreatic β‐cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes. Issue 8 (16th May 2016) Authors: Mari, A.; Del Prato, S.; Ludvik, B.; Milicevic, Z.; de la Peña, A.; Shurzinske, L.; Karanikas, C. A.; Pechtner, V. Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 8(2016) Page Start: 834 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early fasting glucose measurements can predict later glycaemic response to once weekly dulaglutide. Issue 3 (21st July 2015) Authors: Grunberger, G.; Forst, T.; Fernández Landó, L.; Pechtner, V.; Shaginian, R.; Jia, N.; Gough, S. Journal: Diabetic medicine Issue: Volume 33:Issue 3(2016:Mar.) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment satisfaction in people with type 2 diabetes mellitus treated with once‐weekly dulaglutide: data from the AWARD‐1 and AWARD‐3 clinical trials. Issue 9 (27th July 2015) Authors: Reaney, M.; Yu, M.; Lakshmanan, M.; Pechtner, V.; van Brunt, K. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 9(2015:Sep.) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗